Literature DB >> 8552231

Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography.

S L Eastwood1, P J Harrison.   

Abstract

Synaptic alterations have been suggested, largely on theoretical grounds, to occur in the brain in schizophrenia. The messenger RNA encoding synaptophysin, a presynaptic terminal protein, is reduced in the medial temporal lobe in the disease, but immunocytochemical and immunoblotting data have not produced clear evidence for a loss of the encoded protein. Here we have used immunoautoradiography with an antisynaptophysin monoclonal antibody and a 35S-labelled secondary antibody in medial temporal lobe sections from 11 schizophrenics and 14 matched controls. In the schizophrenic cases there was an overall loss of synaptophysin (P < 0.02). Analysis by subfield showed significant reductions in the right dentate gyrus molecular layer, subiculum and parahippocampal gyrus, with similar trends in most other subfields. These data confirm that synaptophysin expression is decreased within the medial temporal lobe in schizophrenia. In the respect that synaptophysin is a marker of synaptic density, our findings suggest that reduced synaptic density may be a feature of the molecular neuropathology of the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8552231     DOI: 10.1016/0306-4522(95)00324-c

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  27 in total

Review 1.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.

Authors:  C Konradi; S Heckers
Journal:  Biol Psychiatry       Date:  2001-11-15       Impact factor: 13.382

Review 2.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 3.  Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders.

Authors:  Katsunori Kobayashi
Journal:  Mol Neurobiol       Date:  2009-01-08       Impact factor: 5.590

Review 4.  The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Authors:  Wei Hu; Matthew L MacDonald; Daniel E Elswick; Robert A Sweet
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

Review 5.  Models of neurodevelopmental abnormalities in schizophrenia.

Authors:  Susan B Powell
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 6.  Extracellular matrix abnormalities in schizophrenia.

Authors:  Sabina Berretta
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

7.  Post-seizure α-tocopherol treatment decreases neuroinflammation and neuronal degeneration induced by status epilepticus in rat hippocampus.

Authors:  Patrizia Ambrogini; Andrea Minelli; Claudia Galati; Michele Betti; Davide Lattanzi; Silvia Ciffolilli; Marta Piroddi; Francesco Galli; Riccardo Cuppini
Journal:  Mol Neurobiol       Date:  2014-02-02       Impact factor: 5.590

8.  Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring.

Authors:  Hiroshi T Ito; Stephen E P Smith; Elaine Hsiao; Paul H Patterson
Journal:  Brain Behav Immun       Date:  2010-03-19       Impact factor: 7.217

9.  Perinatal oxygen restriction does not result in reduced rat frontal cortex synaptophysin protein levels at adulthood as opposed to postmortem findings in schizophrenia.

Authors:  Carmit Nadri; Galila Agam
Journal:  J Mol Neurosci       Date:  2008-07-15       Impact factor: 3.444

Review 10.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.